P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis
Background & Aims: Our previous studies have provided evidence that p38 mitogen-activated protein kinase (MAPK) is involved in total parenteral nutrition (TPN)-associated complications, but its exact effects and mechanisms have not been fully understood. This study aimed to evaluate the roles of...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cell Physiol Biochem Press GmbH & Co KG
2017-02-01
|
| Col·lecció: | Cellular Physiology and Biochemistry |
| Matèries: | |
| Accés en línia: | http://www.karger.com/Article/FullText/457933 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|